KEGG   DRUG: Nedosiran sodium
Entry
D12723                      Drug                                   
Name
Nedosiran sodium (USAN);
Rivfloza (TN)
Product
Formula
C662H865F19N231O413P57S6.57Na
Exact mass
22285.1018
Mol weight
22295.5323
Remark
Product: D12723<US>
Efficacy
Hepatic lactate dehydrogenase level lowering agent
  Disease
Primary hyperoxaluria type 1 [DS:H00117]
  Type
RNA interference (RNAi) drug
Comment
Treatment of primary hyperoxaluria
Target
LDHA [HSA:3939] [KO:K00016] (mRNA)
Brite
Target-based classification of drugs [BR:br08310]
 Enzymes
  Oxidoreductases (EC1)
   Dehydrogenases
    LDHA
     D12723  Nedosiran sodium (USAN) <US>
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D12723
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D12723
Other DBs
CAS: 2247026-22-6
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system